You're reading the free version. Trader adds the live tape and alerts.
Start tracking
RYTM Exercise Disclosure
Mazabraud Yann · SEC Form 4 · Filed Aug 14, 2026
Exercise
Calculated transaction value
$0
Mazabraud Yann EVP, Head Of International
RYTM
Transaction date
Aug 12, 2026
Public filing date
Aug 14, 2026
Filing lag
Filed 2 days later
RYTM daily price context
Close on/before transaction
$117.6
Aug 12, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Options (Right to Buy) on Common Stock
- Quantity / price
- 46,625 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001649904-26-000007
Filing cohort
Transactions in this filing
Showing 8 of 8
Trades
8
Issuers
1
Estimated value
$6.94M
Buys / sales
0 / 6
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Rhythm Pharmaceuticals, Inc. RYTM | Sale | Aug 12, 2026 | $1.68M |
| Rhythm Pharmaceuticals, Inc. RYTM | Sale | Aug 12, 2026 | $2.12M |
| Rhythm Pharmaceuticals, Inc. RYTM Current | Exercise | Aug 12, 2026 | $0 |
| Rhythm Pharmaceuticals, Inc. RYTM | Sale | Aug 12, 2026 | $2.03M |
| Rhythm Pharmaceuticals, Inc. RYTM | Exercise | Aug 12, 2026 | $317.05K |
| Rhythm Pharmaceuticals, Inc. RYTM | Sale | Aug 12, 2026 | $257.14K |
| Rhythm Pharmaceuticals, Inc. RYTM | Sale | Aug 12, 2026 | $112.86K |
| Rhythm Pharmaceuticals, Inc. RYTM | Sale | Aug 12, 2026 | $413.48K |